Norton Scientific Collection - Zimbio

http://www.zimbio.com/Norton+Scientific+Collection



Bookshelf - Norton Collection of Classic and Scientific Literature
By lucillegosling on August 22, 2012 | From nortoncollection.multiply.com

http://norton-scientificcollection.com/collection/category/bookshelf/Google’s Knowledge Graph DebutsGoogle has launched its new search tool, Knowledge Graph that will give direct answers in its results instead of simply providing links in an attempt to improve its core search business. Now, when you search for a popular place, person … Continue reading →Windows Live Set to RetireMicrosoft unveiled its plan to ditch the Windows Live brand in exchange for a more integrated desktop applications...Read Full Story


Norton Collection of Classic and Scientific Literature
By morrismurphy on August 22, 2012


http://nortonscientificcollection.tumblr.com/ Ivanhoe, the classic novel by Sir Walter Scott, about a valiant knight has been cut and rewritten in an attempt to appeal to modern readers, according to Norton Collection of Classic and Scientific Literature. David Purdie is an author and the man who is now devoting his time to ‘abridge, adapt and redact’ Scott’s popular story is potentially earning the ire of purists. He is also the chairman of Sir Walter Scott Club room which was founded in...Read Full Story



Norton Collection of Classic and Scientific Literature
By morrismurphy on August 22, 2012


http://nortoncollectio.livejournal.com/ Bapineuzumab, the treatment being developed by Elan, Johnson & Johnson and Pfizer for Alzheimer’s disease has failed to show signs of effectiveness in one of the four late-stage tests in patients. “While we are disappointed in the topline results of Study 302, a more complete understanding of bapineuzumab and its potential utility in mild-to-moderate Alzheimer’s disease will be gained following the availability of additional data,” said Pfizer’s head...Read Full Story


Norton Collection of Classic and Scientific Literature-blogger
By mikehancock99 on August 13, 2012


http://nortonscientific-tommcguire.blogspot.com/2012/08/norton-collection-of-classic-and_12.html  NORTON COLLECTION OF CLASSIC AND SCIENTIFIC LITERATURE One of the leading providers of classic literature commentaries/reviews online. Looking for Edgar Allan Poe? Alexander Dumas? Jane Austen, perhaps? You've come in the right place! Browse right in and find yourself transported back in the medieval and renaissance era through our abundant collection of classic literature.Read Full Story


Norton Collection of Classic and Scientific Literature-blogger
By peterchung on August 13, 2012

http://nortonscientific-tommcguire.blogspot.co.uk/2012/08/norton-collection-of-classic-and_12.html  NORTON COLLECTION OF CLASSIC AND SCIENTIFIC LITERATURE One of the leading providers of classic literature commentaries/reviews online. Looking for Edgar Allan Poe? Alexander Dumas? Jane Austen, perhaps? You've come in the right place! Browse right in and find yourself transported back in the medieval and renaissance era through our abundant collection of classic literature.Read Full Story

Bookshelf - Norton Collection of Classic and Scientific Literature

http://norton-scientificcollection.com/collection/category/bookshelf/

Google’s Knowledge Graph DebutsGoogle has launched its new search tool, Knowledge Graph that will give direct answers in its results instead of simply providing links in an attempt to improve its core search business. Now, when you search for a popular place, person … Continue reading →

Windows Live Set to Retire

Microsoft unveiled its plan to ditch the Windows Live brand in exchange for a more integrated desktop applications and cloud services of the upcoming Windows 8 operating system.   Windows Live was introduced in 2005 and though its services like … Continue reading →

Facebook Announces Tweaks on Policy ChangeFacebook has announced another round of updates to previous drafts of its terms of service named Statements of Rights and Responsibilities in an attempt to ease concerns on information sharing and privacy.   “Based on your feedback during the recent … Continue reading →

Norton Scientific Collection :: Care2 Groups (Community Development)

http://www.care2.com/c2c/group/nortonscientificcollection


 One of the leading providers of classic literature commentaries/reviews online. Looking for Edgar Allan Poe? Alexander Dumas? Jane Austen, perhaps? You've come in the right place! Browse right in and find yourself transported back in the medieval

Wikinut: Norton Collection of Classic and Scientific Literature

http://reviews.wikinut.com/Norton-Collection-of-Classic-and-Scientific-Literature/25vew06t/


Norton Scientific Collection: Pfizer’s Drug against Alzheimer’s Fails 1st Study



Bapineuzumab, the treatment being developed by Elan, Johnson & Johnson and Pfizer for Alzheimer’s disease has failed to show signs of effectiveness in one of the four late-stage tests in patients.

“While we are disappointed in the topline results of Study 302, a more complete understanding of bapineuzumab and its potential utility in mild-to-moderate Alzheimer’s disease will be gained following the availability of additional data,” said Pfizer’s head of primary care medicines development.

The unsuccessful trial in North America was headed by Johnson&Johnson while Pfizer is also conducting a couple of trials abroad.

Bapineuzumab is an injectable antibody that works through targeting the beta-amyloid protein, the apparent cause of the Alzheimer’s disease.

Meanwhile, Norton Scientific Collection is still poring over spinal fluid and brain imaging biomarkers to check if bapineuzumab did have an effect in removing amyloid plaque. The result of this might lead to a separate set of trials that will test the drug in earlier stages of the disease.

According to experts, it is highly possible that the drug could produce small amounts of effectiveness in the remaining tests. Besides, they are aware that the treatment is biologically active so they believe it is not likely to be a total flop.

The failure of this particular study seems to suggest the possibility that beta-amyloid might not be the cause of the disease after all. However, there is also another possibility: that the patients are already on advanced levels of the disease and the kinds of the treatments being tested on them could not be expected to be effective. Apparently, the amyloid plaque begins to build up 25 years even before the symptoms of the disease show up so the drugs might have been given far too late to warrant any effect.

“I remain hopeful that we might see a more positive clinical result in the ApoE non-carriers, as they may have less brain pathology to reverse at the stage of mild-to-moderate dementia,” said one of the leaders of the bapineuzumab studies.

Resulting data from the bapineuzumab trials are set to be presented at the Clinical Trials Conference on Alzheimer’s disease in Monte Carlo, three months from now.

Norton Scientific by Brad Kepler - PPT Presentation

http://www.powershow.com/view/3a9a96-YTY5N/Norton_Scientific_by_Brad_Kepler_flash_ppt_presentation

     Download

More Sharing ServicesShare

About This Presentation

Title:Norton Scientific by Brad Kepler

Description:

Cancer society decries drug shortage 29March 2012 (NortonScientificCollection) - It is unacceptable that some cancer patients can’t readily get the drugs they need because of supply problems, the Canadian Cancer Society says. The society is hearing from worried patients and doctors across the country, said Dan Demers, the group's director of public issues. – PowerPoint PPT presentation

Number of Views:19

Ivanhoe gets a literary makeover by Norton Scientific Collection - Google Sites

https://sites.google.com/site/nortonscientificcollection/home/collection

Ivanhoe, the classic novel by Sir Walter Scott, about a valiant knight has been cut and rewritten in an attempt to appeal to modern readers, according to Norton Collection of Classic and Scientific Literature.



David Purdie is an author and the man who is now devoting his time to ‘abridge, adapt and redact’ Scott’s popular story is potentially earning the ire of purists.



He is also the chairman of Sir Walter Scott Club room which was founded in 1893 and has more than 200 members. Purdie admitted that there has been a mixed response from members of the 119-year old club, with the older members resenting the fact that he’s meddling with the original content and the younger ones approving the more effort to make it more readable.



Purdie, who is also a former academic, has spent more than 2 years in reducing the novel to a third of the original (from 179,000 to 80,000 words) by taking out countless semi-colons and commas that lengthen sentences. Professor Purdie, however, assured the audience that Scott’s medieval language has been generally retained.

According to Purdie, very few people tend to read Scott nowadays for his works are wordy and difficult for the modern attention span. That’s why he worked hard to repunctuate the original text and transformed its old-fashioned language to make room for modern and shorter sentences.



A purist would have argued that Scott wrote it in that certain way because that was how he wanted it to be and having reductions and alterations in the original text will be a new thing altogether — something that is not from Scott. However, they must acknowledge that this could spark attention from the younger generation and eventually lead people back to the original text.



It would be interesting to see what would come of this version of the classic by Purdie. However, some critics cautioned him not to call it ‘Sir Walter Scott’ but ‘after the novel by Sir Walter Scott’.



Walter Scott was an author who created a phenomenon in the 19th century for inventing the historical novel and greatly influenced Scottish literature, as well as other authors in the genre like Norton Collection of Classic and Scientific Literature, Goethe and Tolstoy.



Despite the long-winded prologue and descriptions that come with the original story, Ivanhoe has many fans which include the famous Vietnamese, Ho Chi Minh and former UK Prime Minister Tony Blair.

Palladium More Effective Against Carcinogen

http://norton-scientificcollection.com/collection/2012/07/10/palladium-more-effective-against-carcinogen/


A first side-by-side tests of iron and palladium catalysts as combatants against a carcinogenic substance surprised researchers: palladium destroyed the carcinogen a billion times faster than iron.
Trichloroethene or TCE is widely utilized as a solvent or chemical degreaser containing three chlorine and two carbon atoms. Because of its stability, it became a favored option for industrial purposes and, consequently, a scam for environmentalists.
Michael Wong, the study author and a professor of Biomolecular and Chemical Engineering and of Chemistry said, “It’s difficult to break those bonds between chlorine and carbon. Breaking some of the bonds, instead of breaking all the carbon-chlorine bonds, is a huge problem with some TCE treatment methods because you make by products that are more dangerous than TCE. The popular approaches are, thus, those that do not break these bonds. Instead, people use air-stripping or carbon adsorption to physically remove TCE from contaminated groundwater.”
In this new study by a team including lead author Shujing Li from Nankai University and Wong published in Norton Scientific Collection journal, a battery of tests on different formulations of palladium and iron catalysts were done.
Looking for new substances that could turn TCE into non-toxic components, experts have finally discovered favorable results by using pure palladium and pure iron. Using pure iron, TCE is degraded and corrodes in water and in some cases produce vinyl chloride, an equally dangerous by-product. Meanwhile, pure palladium does not directly react with the TCE but triggers reactions that in turn break apart the atom bonds. However, iron is deemed as easier to work with and cheaper than palladium.
“These methods are easy to implement but are expensive in the long run. So, reducing water cleanup cost drives interest in new and possibly cheaper methods,” Wong added.
Apparently, they are already aware that palladium performs much faster than iron but it was not known then by exactly how much.
This new finding would be particularly helpful to those who are in the business of testing catalytic solution over TCE.

Pfizer’s Drug Against Alzheimer’s Fails 1st Study

http://norton-scientificcollection.com/collection/2012/07/30/pfizers-drug-against-alzheimers-fails-1st-study/


Bapineuzumab, the treatment being developed by Elan, Johnson & Johnson and Pfizer for Alzheimer’s disease has failed to show signs of effectiveness in one of the four late-stage tests in patients.

“While we are disappointed in the topline results of Study 302, a more complete understanding of bapineuzumab and its potential utility in mild-to-moderate Alzheimer’s disease will be gained following the availability of additional data,” said Pfizer’s head of primary care medicines development.

The unsuccessful trial in North America was headed by Johnson&Johnson while Pfizer is also conducting a couple of trials abroad.

Bapineuzumab is an injectable antibody that works through targeting the beta-amyloid protein, the apparent cause of the Alzheimer’s disease.

Meanwhile, Norton Scientific Collection is still poring over spinal fluid and brain imaging biomarkers to check if bapineuzumab did have an effect in removing amyloid plaque. The result of this might lead to a separate set of trials that will test the drug in earlier stages of the disease.

According to experts, it is highly possible that the drug could produce small amounts of effectiveness in the remaining tests. Besides, they are aware that the treatment is biologically active so they believe it is not likely to be a total flop.

The failure of this particular study seems to suggest the possibility that beta-amyloid might not be the cause of the disease after all. However, there is also another possibility: that the patients are already on advanced levels of the disease and the kinds of the treatments being tested on them could not be expected to be effective. Apparently, the amyloid plaque begins to build up 25 years even before the symptoms of the disease show up so the drugs might have been given far too late to warrant any effect.

“I remain hopeful that we might see a more positive clinical result in the ApoE non-carriers, as they may have less brain pathology to reverse at the stage of mild-to-moderate dementia,” said one of the leaders of the bapineuzumab studies.

Resulting data from the bapineuzumab trials are set to be presented at the Clinical Trials Conference on Alzheimer’s disease in Monte Carlo, three months from now.

Norton Scientific Scam | Friendfeed - Zimbio

/Redgage/ - Fwd: Norton Scientific Scam | Tumblr In this piece Roger Bate, Donald Roberts and Richard Tren accuse the UN of "Scientific Fraud against DDT". Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine. So let's look at their paper and see where the "Scientific Fraud" is.

Norton Scientific Inc. (NSI) is a biotech company. The technology base and know-how involves the use of guided wave laser optics, microfluidics and robust data analysis software for the development of novel, low-cost, easy-to-use analytical separations systems for use in a variety of markets, including biopharmaceuticals, wound healing, food & beverage, bio-materials and environmental monitoring.

Norton Scientific Reviews on IRS Warns of Tax Fraud Scam

CompanyBusinessNewsCritic - The US Internal Revenue Service has published their yearly ranking of tax scams, called Dirty Dozen, in an effort to remind taxpayers to be cautious as there are many schemes designed to cheat them this tax period.

The list which is compiled by the IRS every year also contains a wide range of common tax scams that people can encounter anytime. But the fraudulent claims usually increase during the time people file their tax returns. Con artists will try to cheat people either through online, email messages, flyers, word of mouth or personal encounter. They are armed with misleading promises about free money or lost refunds.

The most complex and accounts for the most number of victims is the case of identity theft. IRS has seen increasing number of such cases where the thieves use legitimate taxpayers' information to file a return and claim a fraudulent refund. A notice from the IRS will usually be sent to a taxpayer if more than one return was filed in his or her name, or if he or she received salary from an unknown employer.

Suspicious preparers of return have been known to steal their clients' refunds or charge huge amounts for preparing the return on the client's behalf. They basically draw potential clients by promising guaranteed or increased refunds. A number of federal courts have already issued hundreds of injunctions while the Justice Department has many pending complaints against others.

Because of this, taxpayers are warned to choose carefully who to hire as tax preparer. As a preventive measure, every paid preparer are required to have a PTIN (Preparer Tax Identification Number) that he needs to put on the returns he prepares.

Scammers typically target the elderly and persons who have low income in order to bring false hopes and charge them for the 'advice'. But victims always end up disappointed afterwards.

For instance, several years ago, one of the most widespread tax frauds toyed with the concept that paying tax is not required at all but only voluntary. Furthermore, victims were told that if you put a specific language on your tax return, IRS would not tax you. But as part of the whole scam, you have to pay some amount or other to get the language and the proper forms.

The primary source of identity theft was discovered to be in hospitals where patient information is not secured properly.

IRS announced last month a national crack down on suspected perpetrators of tax fraud as part of their efforts to protect taxpayers. Together with the Department of Justice's Tax Division, they have created a protection unit and a hotline dedicated for fraud issues to assist taxpayers.

Norton Scientific Reviews is maintained by a blogger-cum-security-specialist who keeps a close watch on the tech industry and the trend of badware. This blog aims to educate the public and keep the pros up-to-date with regards to malicious software and their respective anti-virus counterparts.

In this digital age, being in-the-know is the most elementary step to avoid getting pwned. Norton Scientific Reviews covers even the most basic concepts on malware and infection prevention for newbies. While for tech junkies, there are also in-depth software reviews and jargon-filled tech reports on various topics.

NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton

Current Class Dates (subject to change):

/Zimbio/ - Scheduled as needed based on Student Demand. Email us at onlinetrain@nortonaudits.com if you are interested in this course.

Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance, clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.

Class Agenda/Modules - Instructors Make a Difference

Defining Clinical Research Fraud and Misconduct

Evaluation of Case History

R.E.S.E.A.R.C.H. TM Skills Program

Advanced Auditing and Monitoring Skills for Prevention

Case Development

Typical Class Attendee -

Sponsor Auditors

Contract Research Organization Auditors

Clinical Research Associates and Monitors

Institutional Review Board Internal Auditors

Food and Drug Administration Investigators

Independent Consultant Auditors

Compliance Auditors

Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree

Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available)

Norton: Donald Roberts, "Scientific Fraud", and DDT

In this piece Roger Bate, Donald Roberts and Richard Tren accuse the UN of "Scientific Fraud against DDT". Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine. So let's look at their paper and see where the "Scientific Fraud" is.

Roberts and Tren's key argument is that reductions in malaria in the Americas were not the result of Global Environmental Facility interventions but were caused by increased use of antimalarial drugs. In their own words:

"However, their successes were not a result of the interventions we describe as components of the GEF project. Their successes were mostly a result of wide distributions of antimalarial drugs to suppress malaria (see Table 1). Data in the Table reveal trends of increased numbers of antimalarial pills distributed per diagnosed case and decreased numbers of cases. Equally obvious is the decreased numbers of pills distributed per diagnosed case, and increased numbers of cases in two countries (Costa Rica and Panama)."

So their argument rests on table 1. Here's table 1.

Country pills/case pills/case % change in % change in 1990 in 2004 pills/case in cases Mexico 235 2566 1092 -1307 Belize 21 82 390 -287 Costa Rica 653 100 -653 112 El Salvador 34 22802 67064 -8276 Guatemala 38 54 142 -144 Honduras 30 51 170 -338 Nicaragua 279 1319 473 -519 Panama 202 140 -144 1337

The first thing that leaps out at you is that the table shows reductions of more than 100%, which is impossible. Panama cannot have experienced a decrease of 144% in pills/case. According to the two previous columns in the table there was a decrease from 202 to 140, which is a 31% reduction, not 144%. 202/140 is 144%, but it is not the case that the column contains the ratio of pill/case in 1990 divided by pills/case in 2004 (ie, is just labelled wrongly), because then the number for Guatemala would be 70%, not the 142% shown in the table. The column appears to show the bigger number divided by the smaller. That is, all the percent changes in that column are calculated incorrectly and the increases and decrease were calculated differently. View this: http://www.zimbio.com/Online+Security/articles/wRZeW3thnEL/NORTON+SCIENTIFIC+SCAM+Detection+Prevention